We Seek to Empower Providers to Expedite Access to Care

We are developing products that enable providers to reliably identify behavioral health conditions earlier and expedite access to treatments years earlier than today’s standard of care.


The Current System is Broken

The average age of an autism diagnosis has remained at 4.3 years of age for over 15 years. This means most children receive treatments after the critical early intervention window.

image showing age when cognoa helps and treat conditions

Cognoa Will Help Providers Fill a Void in Care, Starting with Autism.

We are developing precision digital medicine devices that:


Are Clinically Validated

Validated through multiple robust clinical studies.


Increase Provider Efficiency

Reduces the time and steps needed to secure a diagnosis.


Easy to Implement

Fits into existing workflow. Ordered, dispensed and paid for utilizing existing healthcare infrastructure.

Our Lead Prescription
Digital Medicine Products

first digital diagnostic


The First Digital
Diagnostic Aid for Autism

We conduct clinical studies to validate the performance of our devices. Cognoa’s ASD Diagnostic Device will help primary care providers to identify autism in children between the ages of 18 and 72 months of age.

How It Works

Image sequence showing how diagnostic product works.
Image sequence showing how diagnostic product works.


Digital Therapeutic

Designed for use at home with parents and used in conjunction with existing therapies, Cognoa’s ASD Therapeutic will help improve social-emotional reciprocity in children diagnosed with autism between the ages 3 and 7 years.

How it works

  • Delivered via smart-phone
  • Parent/child interact together
digital therapeutic product

Prescribed Digital Medicines, Dispensed and Paid for, within the Existing Healthcare Infrastructure.

image-utilizes existing healthcare infrastructure
Utilizes Existing Healthcare Infrastructure graphic

Join us in advancing the standard of care.